oxidopamine has been researched along with Low Back Pain in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Low Back Pain: Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, S | 1 |
| Konttinen, YT | 1 |
| Tokunaga, Y | 1 |
| Maeda, T | 1 |
| Hukuda, S | 1 |
| Santavirta, S | 1 |
1 other study available for oxidopamine and Low Back Pain
| Article | Year |
|---|---|
Tyrosine hydroxylase-immunoreactive nerve fibres in rat posterior longitudinal ligament.
Topics: Animals; Biomarkers; Longitudinal Ligaments; Low Back Pain; Lumbar Vertebrae; Male; Microscopy, Immu | 1997 |